Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| NF-kappa B | 19 | 2023 | 306 | 3.250 |
Why?
|
| I-kappa B Kinase | 9 | 2022 | 40 | 3.010 |
Why?
|
| I-kappa B Proteins | 12 | 2019 | 38 | 1.510 |
Why?
|
| NF-kappa B p50 Subunit | 5 | 2023 | 13 | 1.350 |
Why?
|
| Protein Multimerization | 5 | 2020 | 97 | 1.200 |
Why?
|
| Crystallography, X-Ray | 13 | 2023 | 237 | 1.090 |
Why?
|
| DNA | 11 | 2023 | 549 | 1.060 |
Why?
|
| Interleukin-6 | 2 | 2023 | 140 | 0.970 |
Why?
|
| Models, Molecular | 14 | 2019 | 751 | 0.800 |
Why?
|
| Lysophospholipids | 2 | 2011 | 19 | 0.760 |
Why?
|
| Multiprotein Complexes | 2 | 2020 | 53 | 0.760 |
Why?
|
| Skeletal Muscle Myosins | 1 | 2019 | 1 | 0.740 |
Why?
|
| Myosin Light Chains | 1 | 2019 | 5 | 0.740 |
Why?
|
| Myosin Heavy Chains | 1 | 2019 | 19 | 0.730 |
Why?
|
| Protein Isoforms | 2 | 2019 | 121 | 0.730 |
Why?
|
| Protein Structure, Tertiary | 8 | 2019 | 383 | 0.730 |
Why?
|
| Recombinant Proteins | 6 | 2020 | 485 | 0.720 |
Why?
|
| Antibody Specificity | 2 | 2017 | 75 | 0.700 |
Why?
|
| Antibodies, Monoclonal | 2 | 2011 | 282 | 0.670 |
Why?
|
| Protein Binding | 11 | 2022 | 913 | 0.650 |
Why?
|
| Leukotrienes | 1 | 2017 | 4 | 0.620 |
Why?
|
| Cysteine | 1 | 2017 | 88 | 0.590 |
Why?
|
| Protein Conformation | 11 | 2017 | 350 | 0.580 |
Why?
|
| Colitis | 1 | 2017 | 64 | 0.580 |
Why?
|
| DNA-Binding Proteins | 5 | 2018 | 522 | 0.570 |
Why?
|
| Protein Engineering | 1 | 2014 | 40 | 0.480 |
Why?
|
| Immunoglobulin Fab Fragments | 2 | 2011 | 12 | 0.470 |
Why?
|
| Transcription Factor RelA | 8 | 2022 | 37 | 0.460 |
Why?
|
| Dimerization | 11 | 2009 | 102 | 0.430 |
Why?
|
| Armadillo Domain Proteins | 1 | 2011 | 2 | 0.410 |
Why?
|
| Molecular Chaperones | 1 | 2011 | 61 | 0.390 |
Why?
|
| Animals | 18 | 2023 | 14307 | 0.370 |
Why?
|
| Antigen-Antibody Complex | 1 | 2009 | 19 | 0.360 |
Why?
|
| Sphingosine | 1 | 2009 | 21 | 0.360 |
Why?
|
| Drosophila Proteins | 1 | 2011 | 162 | 0.350 |
Why?
|
| Drosophila melanogaster | 3 | 2019 | 168 | 0.340 |
Why?
|
| Signal Transduction | 4 | 2023 | 1802 | 0.340 |
Why?
|
| Leucine Zippers | 1 | 2008 | 5 | 0.340 |
Why?
|
| Phosphorylation | 5 | 2022 | 878 | 0.340 |
Why?
|
| Structure-Activity Relationship | 3 | 2020 | 376 | 0.330 |
Why?
|
| Mutant Proteins | 2 | 2020 | 48 | 0.330 |
Why?
|
| Humans | 21 | 2023 | 34853 | 0.330 |
Why?
|
| Bacterial Proteins | 3 | 2019 | 520 | 0.310 |
Why?
|
| Solutions | 2 | 2020 | 60 | 0.310 |
Why?
|
| Amino Acid Sequence | 5 | 2019 | 1124 | 0.290 |
Why?
|
| Nuclear Proteins | 1 | 2008 | 287 | 0.280 |
Why?
|
| ras Proteins | 1 | 2006 | 49 | 0.270 |
Why?
|
| Binding Sites | 8 | 2021 | 597 | 0.250 |
Why?
|
| Polyribonucleotides | 1 | 2004 | 2 | 0.250 |
Why?
|
| Molecular Mimicry | 1 | 2004 | 16 | 0.250 |
Why?
|
| X-Rays | 1 | 2023 | 17 | 0.240 |
Why?
|
| Enzyme Activation | 2 | 2014 | 423 | 0.220 |
Why?
|
| Isatin | 1 | 2022 | 1 | 0.220 |
Why?
|
| Polyubiquitin | 1 | 2022 | 6 | 0.220 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2016 | 168 | 0.220 |
Why?
|
| RNA | 1 | 2004 | 234 | 0.210 |
Why?
|
| Mice | 6 | 2023 | 5668 | 0.210 |
Why?
|
| Myosins | 2 | 2011 | 25 | 0.200 |
Why?
|
| Molecular Sequence Data | 5 | 2011 | 1490 | 0.200 |
Why?
|
| Substrate Specificity | 2 | 2014 | 186 | 0.200 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 43 | 0.200 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 117 | 0.190 |
Why?
|
| Protein Stability | 1 | 2020 | 40 | 0.190 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2020 | 40 | 0.190 |
Why?
|
| Adenosine Triphosphate | 1 | 2021 | 180 | 0.190 |
Why?
|
| Myofibrils | 1 | 2019 | 7 | 0.190 |
Why?
|
| Response Elements | 1 | 2019 | 52 | 0.180 |
Why?
|
| Ovarian Neoplasms | 1 | 2023 | 303 | 0.180 |
Why?
|
| Mutation | 2 | 2016 | 1023 | 0.170 |
Why?
|
| Genome, Human | 1 | 2019 | 112 | 0.170 |
Why?
|
| Immune System | 1 | 2019 | 40 | 0.170 |
Why?
|
| Base Sequence | 4 | 2008 | 932 | 0.170 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2019 | 117 | 0.170 |
Why?
|
| Coenzymes | 1 | 2018 | 11 | 0.170 |
Why?
|
| Metals | 1 | 2019 | 95 | 0.170 |
Why?
|
| Nuclear Localization Signals | 3 | 2006 | 14 | 0.160 |
Why?
|
| Permeability | 1 | 2017 | 67 | 0.150 |
Why?
|
| Blood Vessels | 1 | 2017 | 32 | 0.150 |
Why?
|
| Immunization | 1 | 2017 | 90 | 0.150 |
Why?
|
| Acute Disease | 1 | 2017 | 141 | 0.150 |
Why?
|
| Metyrapone | 1 | 2016 | 5 | 0.150 |
Why?
|
| Bacillus megaterium | 1 | 2016 | 3 | 0.150 |
Why?
|
| NADPH-Ferrihemoprotein Reductase | 1 | 2016 | 9 | 0.150 |
Why?
|
| Palmitic Acid | 1 | 2016 | 24 | 0.140 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2016 | 82 | 0.140 |
Why?
|
| Escherichia coli | 3 | 2011 | 436 | 0.130 |
Why?
|
| Protein Structure, Secondary | 3 | 2011 | 172 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 756 | 0.130 |
Why?
|
| Marinobacter | 1 | 2013 | 1 | 0.120 |
Why?
|
| Borates | 1 | 2013 | 4 | 0.120 |
Why?
|
| Iron-Binding Proteins | 1 | 2013 | 3 | 0.120 |
Why?
|
| Cell Nucleus | 2 | 2018 | 351 | 0.120 |
Why?
|
| Carrier Proteins | 2 | 2006 | 287 | 0.120 |
Why?
|
| Chromatography, Gel | 1 | 2013 | 46 | 0.120 |
Why?
|
| Protein Structure, Quaternary | 1 | 2013 | 61 | 0.120 |
Why?
|
| Surface Plasmon Resonance | 2 | 2009 | 20 | 0.110 |
Why?
|
| Sequence Alignment | 2 | 2011 | 257 | 0.110 |
Why?
|
| Flight, Animal | 1 | 2011 | 2 | 0.110 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 1300 | 0.110 |
Why?
|
| Transfection | 1 | 2013 | 496 | 0.110 |
Why?
|
| Transgenes | 1 | 2011 | 57 | 0.110 |
Why?
|
| Pliability | 1 | 2011 | 5 | 0.100 |
Why?
|
| Scattering, Small Angle | 1 | 2011 | 7 | 0.100 |
Why?
|
| Protein Subunits | 2 | 2008 | 85 | 0.100 |
Why?
|
| Circular Dichroism | 3 | 2019 | 60 | 0.100 |
Why?
|
| Caenorhabditis elegans | 1 | 2011 | 74 | 0.090 |
Why?
|
| Binding Sites, Antibody | 1 | 2009 | 19 | 0.090 |
Why?
|
| Peptides | 2 | 2006 | 308 | 0.090 |
Why?
|
| Antibody Affinity | 1 | 2009 | 25 | 0.090 |
Why?
|
| Molecular Conformation | 1 | 2009 | 150 | 0.090 |
Why?
|
| Aplysia | 2 | 2006 | 19 | 0.090 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2009 | 109 | 0.080 |
Why?
|
| Models, Biological | 2 | 2009 | 642 | 0.080 |
Why?
|
| Casein Kinase II | 1 | 2008 | 15 | 0.080 |
Why?
|
| Gene Expression | 1 | 2011 | 639 | 0.080 |
Why?
|
| Crystallization | 2 | 2016 | 82 | 0.080 |
Why?
|
| Serine | 1 | 2008 | 72 | 0.080 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2008 | 52 | 0.080 |
Why?
|
| Receptors, Nicotinic | 2 | 2006 | 91 | 0.080 |
Why?
|
| Glycine | 1 | 2008 | 44 | 0.080 |
Why?
|
| Calcium | 1 | 2009 | 445 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 2019 | 484 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2008 | 180 | 0.070 |
Why?
|
| Receptors, Cholinergic | 1 | 2006 | 28 | 0.070 |
Why?
|
| Elapid Venoms | 1 | 2006 | 16 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2023 | 2128 | 0.070 |
Why?
|
| Acetylcholine | 1 | 2006 | 68 | 0.070 |
Why?
|
| Nicotinic Antagonists | 1 | 2005 | 28 | 0.070 |
Why?
|
| Nicotinic Agonists | 1 | 2005 | 68 | 0.070 |
Why?
|
| Ankyrin Repeat | 1 | 2004 | 1 | 0.060 |
Why?
|
| Deuterium | 1 | 2004 | 10 | 0.060 |
Why?
|
| Synapses | 1 | 2006 | 173 | 0.060 |
Why?
|
| Hydrogen | 1 | 2004 | 47 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2006 | 338 | 0.060 |
Why?
|
| Transcription Factor RelB | 1 | 2023 | 8 | 0.060 |
Why?
|
| Carboplatin | 1 | 2023 | 13 | 0.060 |
Why?
|
| Tumor Necrosis Factors | 1 | 2023 | 12 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2023 | 32 | 0.060 |
Why?
|
| Female | 2 | 2023 | 19873 | 0.050 |
Why?
|
| 4-Butyrolactone | 1 | 2022 | 11 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 133 | 0.050 |
Why?
|
| Stem Cells | 1 | 2023 | 132 | 0.050 |
Why?
|
| Kinetics | 2 | 2016 | 650 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 310 | 0.050 |
Why?
|
| Zinc Sulfate | 1 | 2019 | 2 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2021 | 467 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 2019 | 103 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 1999 | 5 | 0.040 |
Why?
|
| Static Electricity | 1 | 1999 | 75 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 1999 | 86 | 0.040 |
Why?
|
| Chromatin | 1 | 2019 | 164 | 0.040 |
Why?
|
| Ribosomal Proteins | 1 | 2018 | 19 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 984 | 0.040 |
Why?
|
| Drug Design | 1 | 2019 | 154 | 0.040 |
Why?
|
| Hydroxylation | 1 | 2016 | 14 | 0.040 |
Why?
|
| Electron Transport | 1 | 2016 | 38 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 200 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 407 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2019 | 653 | 0.030 |
Why?
|
| Ligands | 2 | 2006 | 317 | 0.030 |
Why?
|
| Cell Line | 1 | 2018 | 1289 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 396 | 0.030 |
Why?
|
| Boron | 1 | 2013 | 6 | 0.030 |
Why?
|
| Anions | 1 | 2013 | 39 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 968 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 46 | 0.030 |
Why?
|
| Iron | 1 | 2013 | 204 | 0.030 |
Why?
|
| Chromatography, Affinity | 1 | 2011 | 64 | 0.030 |
Why?
|
| Cholinergic Antagonists | 1 | 2006 | 8 | 0.020 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2006 | 41 | 0.020 |
Why?
|
| Ion Channel Gating | 1 | 2006 | 81 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2006 | 207 | 0.020 |
Why?
|
| Temperature | 1 | 2006 | 275 | 0.020 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2004 | 29 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 85 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2004 | 100 | 0.020 |
Why?
|
| Amides | 1 | 2004 | 66 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 249 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 555 | 0.010 |
Why?
|
| Fluorescence Polarization Immunoassay | 1 | 1998 | 1 | 0.010 |
Why?
|
| DNA Primers | 1 | 1998 | 269 | 0.010 |
Why?
|